Skip to content
Search

Latest Stories

NPA: Hub and spoke impact assessment proves justification for pharmacy cut was hollow

The National Pharmacy Association (NPA) has called for an immediate reconsideration on pharmacy funding as the official impact assessment of hub and spoke dispensing reveals that only limited extent of savings may be possible under the model.

The total savings to the pharmacy sector’s operational costs are calculated to be approximately £1 million by 2024, when the current contractual framework comes to an end. This compares to well over a billion pounds withheld from the sector over the contract period (2019-24), due to flat funding below inflation.


The NPA claims that the real-terms funding cuts since 2019, and indeed earlier cuts, were based in part on government promises of cost savings through hub and spoke.

Nick Kaye, NPA vice-chair, said:“The current 5-year funding deal promised clinical service developments, but with a downward ratchet on funding predicated on dispensing efficiencies. The promise was that independents would have the same opportunity as large multiples to secure the benefits of outsourcing elements of dispensing to a hub. Now it is clear that hundreds of independents won’t be in a position to benefit at all and that the savings for others will be miniscule compared to the money taken out of the global sum.

“These official figures confirm that there is an enormous gap between money taken out and any potential savings from hub and spoke.

Kaye called for an "honest conversation about efficiencies - a conversation that reflects the reality for independents struggling to survive."

“The government should go back to the drawing board on pharmacy funding, now that one of the central arguments for cuts has been exposed as completely hollow,” he added.

According to NPA calculation, had the global sum increased in line with inflation (including future projections) throughout the five years of the deal to 2024, more than £1.2bn in funding would have flowed to community pharmacy by 2024.

The Department of Health and Social Care impact assessment accompanied the launch of a consultation on legislative changes needed to permit hub and spoke between different legal entities. The consultation ends on 8 June.

More For You

The new funding uplift our commitment to rebuilding the sector: Kinnock
The new funding uplift our commitment to rebuilding the sector: Kinnock
Health minister Stephen Kinnock

Community pharmacy to play "big role" in NHS 10-year Health Plan, says Kinnock

Pharmacy minister Stephen Kinnock has insisted that community pharmacy have an integral part to play in the government’s long-term plan to refocus healthcare from hospitals to the community.

Through the new NHS 10-Year Plan, the government aims to transform the NHS by shifting from hospital to community, analogue to digital, and sickness to prevention.

Keep ReadingShow less
AAH Pharmaceuticals introduces 20 new electric vans to its delivery fleet

18 vans have been added to the AAH DC in Ruislip, and another 2 to their branch in Glasgow

Photo credit: AAH

AAH Pharmaceuticals adds 20 new electric vans to reduce carbon emissions

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced 20 new electric vans to its delivery fleet, marking a significant step forward in its Carbon Reduction Plan, which is aligned to the NHS net zero targets.

Eighteen of the new electric vehicles have been deployed at the AAH distribution centre in Ruislip, with the remaining two now in operation at its Glasgow branch.

Keep ReadingShow less
Operation Subaru:

Some of the medicines seized in raids today. Credit: MHRA

12 arrested in MHRA’s biggest medicines trafficking crackdown

Twelve people have been arrested in a series of dawn raids across the West Midlands and the Northwest of England today (29 April), as part of the biggest criminal investigation ever undertaken by the Medicines and Healthcare products Regulatory Agency (MHRA) into organised medicines trafficking.

The suspects were detained on suspicion of involvement in organised crime, conspiracy to sell or supply controlled and unlicensed medicines, and money laundering.

Keep ReadingShow less
Sukhi Basra named NPA vice-chair in historic leadership update with Olivier Picard as new chair

Olivier Picard steps up as NPA chair, Basra as vice-chair

Olivier Picard named new NPA chair

The National Pharmacy Association (NPA) has announced Olivier Picard as the organisation’s new chair.

Picard replaces Nick Kaye whose term comes to an end this week.

Keep ReadingShow less
 RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care

Professor Tony Avery OBE

Pic credit: RPS

Professor Tony Avery OBE awarded RPS Honorary Fellowship

The Royal Pharmaceutical Society (RPS) Assembly has awarded an Honorary Fellowship to Professor Tony Avery OBE in recognition of his outstanding contribution to prescribing safety and patient care.

The Honorary Fellowship is given to those who are not eligible for membership of the Society but have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.

Keep ReadingShow less